Lc. Adding et al., GADOLINIUM CHLORIDE INHIBITION OF PULMONARY NITRIC-OXIDE PRODUCTION AND EFFECTS ON PULMONARY CIRCULATION IN THE RABBIT, Pharmacology & toxicology, 83(1), 1998, pp. 8-15
Nitric oxide is an important regulator of pulmonary vascular resistanc
e. Pulmonary nitric oxide formation is detectable in exhaled air and t
he synthesis is partly stretch-dependent. Gadolinium chloride (GdCl3)
reduces pulmonary nitric oxide formation, possibly by interference wit
h stretch-activated cellular calcium influx, but the effect on pulmona
ry circulation is not known. We therefore measured exhaled nitric oxid
e and pulmonary vascular resistance in anaesthetised rabbits, and comp
ared the effects of GdCl3 with those of an nitric oxide-synthase inhib
itor (L-N-omega-nitro-arginine methyl ester, L-NAME). Both GdCl3 and L
-NAME reduced nitric oxide in exhaled air and increased pulmonary vasc
ular resistance. However, the increase in pulmonary vascular resistanc
e was more pronounced with GdCl3 than with L-NAME. A 50% reduction of
exhaled nitric oxide caused by either GdCl3 or L-NAME was accompanied
by a 90% or 17% increase in pulmonary vascular resistance respectively
. Inhaled nitric oxide (40 ppm) reduced pulmonary vascular resistance
after L-NAME, but not after GdCl3 infusion. Infusion of glyceryltrinit
rate reduced pulmonary vascular resistance after GdCl3 infusion. GdCl3
caused hypoxaemia, probably due to vasoconstriction since lung weight
was unaltered. Thus GdCl3 can induce a marked increase in pulmonary v
ascular resistance, which partly may be caused by inhibition of pulmon
ary nitric oxide formation. Intact stretch-activated calcium channels
may be important for maintenance of normal pulmonary vascular function
.